Cover Image
市場調查報告書

神經補綴的全球市場 (∼2022年):輸出神經 (認識補綴、運動補綴)、輸入神經 (人工電子耳、視網膜移植)

Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques(Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application(Epilepsy, Paralysis, Alzheimer's Disease) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 600767
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
Back to Top
神經補綴的全球市場 (∼2022年):輸出神經 (認識補綴、運動補綴)、輸入神經 (人工電子耳、視網膜移植) Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques(Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application(Epilepsy, Paralysis, Alzheimer's Disease) - Global Forecast to 2022
出版日期: 2018年01月22日 內容資訊: 英文 120 Pages
簡介

神經補綴的市場在預測期間內預計以12.4%的年複合成長率發展,從2017年的58億4000萬美元,成長到2022年的104億8000萬美元的規模。神經系統疾病的增加,聽覺障礙的罹患率的增加,糖尿病盛行率的擴大,事故和受傷截肢數量的增加等要素促進該市場的成長。

本報告提供全球神經補綴的市場調查,市場定義和概要,市場成長的各種影響因素及市場機會分析,各神經補綴類型、技術、用途、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 歐洲的輸出神經補綴市場:各用途、各國
  • 地區分析:各國
  • 輸出神經補綴市場:各類型

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 市場分析、預測:各類型

  • 簡介
  • 輸出神經補綴
    • 運動補綴
    • 認識補綴
  • 輸入神經補綴
    • 人工電子耳
    • 生物工學蓼藍/視網膜移植

第7章 市場分析、預測:各技術

  • 簡介
  • 脊髓刺激
  • 腦深部刺激
  • 迷走神經刺激
  • 薦椎神經刺激
  • 經顱磁刺激

第8章 市場分析、預測:各用途

  • 簡介
  • 運動神經原障礙
    • 帕金森氏症
    • 癲癇
  • 生理學的疾病
    • 聽覺處理障礙
    • 眼科疾病
    • 心臟血管疾病
    • 泌尿系統疾病
  • 認知障礙
    • 阿茲海默症
    • 麻痺

第9章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
  • 其他地區

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭模式
    • 產品的市場投入、核准
    • 收購
    • 協定
    • 合併
    • 擴張

第11章 企業簡介

  • MEDTRONIC
  • ABBOTT
  • COCHLEAR
  • BOSTON SCIENTIFIC
  • LIVANOVA
  • SECOND SIGHT
  • MED-EL
  • RETINA IMPLANT
  • SONOVA
  • NEUROPACE
  • NDI MEDICAL
  • NEVRO

第12章 附錄

目錄
Product Code: MD 5908

"Neuroprosthetics market projected to grow at a CAGR of 12.4%"

The neuroprosthetics market was valued at USD 5.84 billion in 2017 and expected to grow at a CAGR of 12.4% to a USD 10.48 billion market by 2022. Factors driving this market include increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries. Availability of alternative treatment, high cost of neuroprosthetics devices, and dearth of trained professionals are the major factors hampering the growth of the market.

"Output neural prosthetics segment is accounted for the largest share in the market"

The neuroprosthetics market is classified on the basis of type into input neural prosthetics and output neural prosthetics. The output neural prosthetics segment accounted for the largest share of this market segment. This growth can be attributed to the increasing neurological disorders.

"Motor neuron disorders segment is expected to register the highest CAGR during the forecast period"

The neuroprosthetics market is classified on the basis of the application into motor neuron disorders, physiological disorders, and cognitive disorders. The motor neuron disorders segment is expected to register the highest growth rate during the forecast period. This growth can be attributed to the increasing neurological disorders such as Parkinson's disease and epilepsy.

"North America is account for the largest regional segment in the market"

Geographically, the neuroprosthetics market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region and rising geriatric population, increasing incidence of peripheral nerve injuries, availability of government funding, and technological advancements.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 35%, Tier 2 - 22% and Tier 3 - 43%
  • By Designation - C level - 15%, Director level - 32%, Others - 53%
  • By Region - North America - 32%, Europe - 27%, Asia - 22%, RoW - 19%

Key players operating in the neuroprosthetics market include Medtronic (US), Boston Scientific (US), Abbott (US), LivaNova (UK), Secong Sight (US), and Cochlear (Australia).

Research Coverage:

The report analyses the neuroprosthetics market by type, technique, application, and region. Apart from comprehensive geographic and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The abovementioned market research data, market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

  • Market Penetration: The report analyzes the neuroprosthetics market on the basis of several segments.
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the neuroprosthetics market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various neuroprosthetics product across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the neuroprosthetics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
  • 1.4. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key Industry Insights
      • 2.1.2.3. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. DATA TRIANGULATION
  • 2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. NEUROPROSTHETICS MARKET OVERVIEW
  • 4.2. EUROPEAN OUTPUT NEURAL PROSTHETICS MARKET, BY APPLICATION AND COUNTRY
  • 4.3. GEOGRAPHIC ANALYSIS OF THE NEUROPROSTHETICS MARKET, BY COUNTRY
  • 4.4. OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing number of patients suffering from neurological disorders and nerve injury
      • 5.2.1.2. Increasing incidence of hearing loss
      • 5.2.1.3. Increasing cases of amputation due to the rising number of accidents & injuries
      • 5.2.1.4. Increasing prevalence of diabetes
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Availability of alternative treatment options
      • 5.2.2.2. High cost of neuroprosthetics and unfavorable reimbursement scenario
      • 5.2.2.3. Dearth of trained professionals
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Higher growth opportunities in emerging economies
      • 5.2.3.2. Expanded target applications and new indications

6. NEUROPROSTHETICS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. OUTPUT NEURAL PROSTHETICS
    • 6.2.1. MOTOR PROSTHETICS
    • 6.2.2. COGNITIVE PROSTHETICS
  • 6.3. INPUT NEURAL PROSTHETICS
    • 6.3.1. COCHLEAR IMPLANTS
    • 6.3.2. BIONIC EYE/RETINAL IMPLANTS

7. NEUROPROSTHETICS MARKET, BY TECHNIQUE

  • 7.1. INTRODUCTION
  • 7.2. SPINAL CORD STIMULATION
  • 7.3. DEEP BRAIN STIMULATION
  • 7.4. VAGUS NERVE STIMULATION
  • 7.5. SACRAL NERVE STIMULATION
  • 7.6. TRANSCRANIAL MAGNETIC STIMULATION

8. NEUROPROSTHETICS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. MOTOR NEURON DISORDERS
    • 8.2.1. PARKINSON'S DISEASE
    • 8.2.2. EPILEPSY
  • 8.3. PHYSIOLOGICAL DISORDERS
    • 8.3.1. AUDITORY PROCESSING DISORDERS
    • 8.3.2. OPHTHALMIC DISORDERS
    • 8.3.3. CARDIOVASCULAR DISORDERS
    • 8.3.4. UROLOGY DISORDERS
  • 8.4. COGNITIVE DISORDERS
    • 8.4.1. ALZHEIMER'S DISEASE
    • 8.4.2. PARALYSIS

9. NEUROPROSTHETICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. REST OF EUROPE
  • 9.4. ASIA PACIFIC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS, 2016
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. PRODUCT LAUNCHES AND APPROVALS
    • 10.3.2. ACQUISITIONS
    • 10.3.3. AGREEMENTS
    • 10.3.4. MERGERS
    • 10.3.5. EXPANSIONS

11. COMPANY PROFILES

(Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1. MEDTRONIC
  • 11.2. ABBOTT
  • 11.3. COCHLEAR
  • 11.4. BOSTON SCIENTIFIC
  • 11.5. LIVANOVA
  • 11.6. SECOND SIGHT
  • 11.7. MED-EL
  • 11.8. RETINA IMPLANT
  • 11.9. SONOVA
  • 11.10. NEUROPACE
  • 11.11. NDI MEDICAL
  • 11.12. NEVRO

*Details on Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INDUSTRY INSIGHTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INCIDENCE OF HEARING LOSS, BY REGION, 2012 (MILLION)
  • TABLE 2: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 4: OUTPUT NEURAL PROSTHETICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: MOTOR PROSTHETICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: COGNITIVE PROSTHETICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: INPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 8: INPUT NEURAL PROSTHETICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: COCHLEAR IMPLANTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: BIONIC EYE/RETINAL IMPLANTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: NEUROPROSTHETICS MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 12: SPINAL CORD STIMULATION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: DEEP BRAIN STIMULATION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: VAGUS NERVE STIMULATION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: SACRAL NERVE STIMULATION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 18: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 19: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NEUROPROSTHETICS MARKET FOR PARKINSON'S DISEASE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NEUROPROSTHETICS MARKET FOR EPILEPSY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 23: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: NEUROPROSTHETICS MARKET FOR AUDITORY PROCESSING DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: NEUROPROSTHETICS MARKET FOR OPHTHALMIC DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: NEUROPROSTHETICS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NEUROPROSTHETICS MARKET FOR UROLOGY DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 29: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: NEUROPROSTHETICS MARKET FOR ALZHEIMER'S DISEASE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NEUROPROSTHETICS MARKET FOR PARALYSIS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: NEUROPROSTHETICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: NEUROPROSTHETICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: NORTH AMERICA: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 36: NORTH AMERICA: INPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 37: NORTH AMERICA: NEUROPROSTHETICS MARKET, BY TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 39: NORTH AMERICA: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 42: US: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: US: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 44: US: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 45: CANADA: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: CANADA: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 47: CANADA: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: NEUROPROSTHETICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: EUROPE: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: EUROPE: INPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 53: EUROPE: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 54: EUROPE: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: EUROPE: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: GERMANY: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: GERMANY: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 59: GERMANY: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 60: UK: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: UK: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 62: UK: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 63: FRANCE: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: FRANCE: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 65: FRANCE: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 66: REST OF EUROPE: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: REST OF EUROPE: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 68: REST OF EUROPE: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: ASIA PACIFIC: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: ASIA PACIFIC: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 71: ASIA PACIFIC: INPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 72: ASIA PACIFIC: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 73: ASIA PACIFIC: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 74: ASIA PACIFIC: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: ASIA PACIFIC: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: ASIA PACIFIC: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: ROW: NEUROPROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: ROW: OUTPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 79: ROW: INPUT NEURAL PROSTHETICS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: ROW: NEUROPROSTHETICS MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 81: ROW: NEUROPROSTHETICS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 82: ROW: NEUROPROSTHETICS MARKET FOR MOTOR NEURON DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 83: ROW: NEUROPROSTHETICS MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: ROW: NEUROPROSTHETICS MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 4: DATA TRIANGULATION METHODOLOGY
  • FIGURE 5: NEUROPROSTHETICS MARKET, BY TYPE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 6: NEUROPROSTHETICS MARKET, BY TECHNIQUE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: NEUROPROSTHETICS MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: NEUROPROSTHETICS MARKET, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: RISING INCIDENCE OF HEARING LOSS AND GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE THE GROWTH OF THE MARKET
  • FIGURE 10: OUTPUT NEURAL PROSTHETICS TO DOMINATE THE EUROPEAN NEUROPROSTHETICS MARKET IN 2017
  • FIGURE 11: FRANCE TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2017-2022)
  • FIGURE 12: MOTOR PROSTHETICS WILL CONTINUE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2017-2022)
  • FIGURE 13: NEUROPROSTHETICS MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
  • FIGURE 14: OUTPUT NEURAL PROSTHETICS SEGMENT TO DOMINATE THE MARKET BETWEEN 2017 AND 2022
  • FIGURE 15: SPINAL CORD STIMULATION, THE LARGEST TECHNIQUE SEGMENT IN THE MARKET
  • FIGURE 16: MOTOR NEURON DISORDERS SEGMENT TO DOMINATE THE NEUROPROSTHETICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: NORTH AMERICA TO DOMINATE THE NEUROPROSTHETICS MARKET IN 2017
  • FIGURE 18: NORTH AMERICA: NEUROPROSTHETICS MARKET SNAPSHOT
  • FIGURE 19: EUROPE: NEUROPROSTHETICS MARKET SNAPSHOT
  • FIGURE 20: ASIA PACIFIC: NEUROPROSTHETICS MARKET SNAPSHOT
  • FIGURE 21: ROW: NEUROPROSTHETICS MARKET SNAPSHOT
  • FIGURE 22: PRODUCT APPROVALS & LAUNCHES- KEY STRATEGY ADOPTED BY PLAYERS BETWEEN 2014 AND 2017
  • FIGURE 23: SHARE OF COMPANIES IN THE NEUROPROSTHETICS MARKET, 2016
  • FIGURE 24: MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 25: ABBOTT: COMPANY SNAPSHOT
  • FIGURE 26: COCHLEAR: COMPANY SNAPSHOT
  • FIGURE 27: BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 28: LIVANOVA: COMPANY SNAPSHOT
  • FIGURE 29: SECOND SIGHT: COMPANY SNAPSHOT
  • FIGURE 30: SONOVA: COMPANY SNAPSHOT
  • FIGURE 31: NEVRO: COMPANY SNAPSHOT
Back to Top